MVASC Trademark

Trademark Overview


On Friday, November 21, 2014, a trademark application was filed for MVASC with the United States Patent and Trademark Office. The USPTO has given the MVASC trademark a serial number of 86461889. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, January 30, 2025. This trademark is owned by MicroVascular Tissues, Inc.. The MVASC trademark is filed in the Pharmaceutical Products category with the following description:

Biological vascular tissue intended for subsequent implantation; Stem cells for medical or veterinary use
mvasc

General Information


Serial Number86461889
Word MarkMVASC
Filing DateFriday, November 21, 2014
Status800 - REGISTERED AND RENEWED
Status DateThursday, January 30, 2025
Registration Number4828818
Registration DateTuesday, October 6, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 5, 2015

Trademark Statements


Goods and ServicesBiological vascular tissue intended for subsequent implantation; Stem cells for medical or veterinary use
Pseudo MarkMICRO VASCULAR

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 1, 2014
Primary Code005
First Use Anywhere DateTuesday, April 15, 2014
First Use In Commerce DateFriday, July 10, 2015

Trademark Owner History


Party NameMicroVascular Tissues, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameMicroVascular Tissues, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBeverly, MA 01915

Party NameMicroVascular Tissues, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBeverly, MA 01915

Trademark Events


Event DateEvent Description
Tuesday, May 5, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 25, 2014NEW APPLICATION ENTERED
Monday, December 1, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 2, 2014NOTICE OF PSEUDO MARK E-MAILED
Wednesday, March 11, 2015ASSIGNED TO EXAMINER
Friday, March 13, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 15, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 5, 2015PUBLISHED FOR OPPOSITION
Wednesday, August 18, 2021TEAS SECTION 8 & 15 RECEIVED
Tuesday, June 30, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, August 15, 2015TEAS STATEMENT OF USE RECEIVED
Saturday, August 15, 2015USE AMENDMENT FILED
Friday, August 28, 2015STATEMENT OF USE PROCESSING COMPLETE
Friday, August 28, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 28, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, August 29, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 6, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, October 6, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Saturday, November 20, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sunday, October 6, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, August 18, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 18, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 18, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, November 20, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, November 20, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, October 7, 2024TEAS SECTION 8 & 9 RECEIVED
Thursday, January 30, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, January 30, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, January 30, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, January 30, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED